Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
14 Cards in this Set
- Front
- Back
patient
effectiveness active respond |
Learn to treat each _______: Summarization of how individual patient differences can affect drug ___________ and drug dosage required (i.e. can affect the amount of drug reaching the ______ site, and/or the abiity of the active site to _________.)
|
|
Age
|
infant
aged |
|
infant
|
immature hepatic and renal systems, inconsistent GI motility, and incomplete development of blood-brain-barrier
|
|
aged
|
deterioration of hepatic and renal systems, also cardiovascular disease.
|
|
Weight
|
dosage based upon amount/kg body ________ or upon surface area.
Especially critical for children. They are NOT small adults. |
|
Sex
|
size difference
amount of fat vs. water pregnancy nursing |
|
Age
Weight Sex Environment Physiological, pharmacological, or pathological state Genetic Assess the predrug status of the individual. |
What are some some other conditions or issues affecting drug responses?
|
|
physical environment
|
temp. (causes vasoconstriction or vasodilation)
altitude |
|
psychosocial issues (environment)
|
Sensory distribution from problem
Placebo effect Compliance issues (ease of use, cost, patient responsibility) |
|
physiological state
|
diurnal rhythms, hormone secretions, water/electrolyte/acid-base balance
|
|
pharmacological state
|
other medications, drug abuse history, tobacco or alcohol use (P450)
|
|
Pathological state
|
hepatic, renal, or cardiovascular disease
special cases: fever (+ aspirin) infection (+ insulin) Pulmonary disease (+anesthetics) |
|
Genetic
|
deficiencies or excesses in enzymes and drug metabolism
-some blacks more sensitive to sulfonamides -some individuals metabolize seizure medications 4X faster than others do. inherited drug receptor disorders (insulin) |
|
Assess the predrug status of the individual
|
helpful especially in areas that might be affected by the drug (+or-)
needed to monitor drug effectiveness and drug toxicities. |